Alto Neuroscience Inc (ANRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANRO | REPL | GLUE | ||
| Company | Alto Neuroscience Inc | Replimune Group Inc | Monte Rosa Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 34.36 | 14.55 | 15.62 | ||
| High | 34.50 | 14.77 | 15.90 | ||
| Low | 33.65 | 13.92 | 14.82 | ||
| Last | 33.96 | 14.33 | 14.91 | ||
| Change | -0.93 | -0.48 | -0.86 | ||
| Percent Change | -2.67% | -3.24% | -5.45% | ||
| Volume | 171,666 | 2,214,486 | 418,651 | ||
| 20-Day Average Volume | 436,696 | 8,170,559 | 1,492,531 | ||
| Previous | 34.89 | 14.81 | 15.77 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 29.62 | 12.17 | 17.34 | ||
| 20-Day Raw Stochastic | 84.31% | 87.89% | 2.06% | ||
| 20-Day Relative Strength | 67.51 | 60.06 | 35.07 | ||
| Weighted Alpha | +240.09 | +166.01 | +57.17 | ||
| Today's Opinion | 100% Buy | 88% Buy | 40% Sell | ||
| Yesterday's Opinion | 100% Buy | 88% Buy | 40% Sell | ||
| Last Month's Opinion | 100% Buy | 80% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.92% since 08/13/26 | -5.33% since 08/13/26 | -5.97% since 08/13/26 | ||
| Low | 29.88 on 08/14/26 | 13.92 on 08/20/26 | 14.70 on 08/18/26 | ||
| High | 35.41 on 08/19/26 | 15.64 on 08/19/26 | 16.20 on 08/19/26 | ||
| 1-Month | |||||
| %Chg | +30.85% since 07/20/26 | +36.82% since 07/20/26 | -36.56% since 07/20/26 | ||
| Low | 25.72 on 07/24/26 | 4.76 on 07/29/26 | 14.70 on 08/18/26 | ||
| High | 35.41 on 08/19/26 | 15.70 on 08/13/26 | 24.23 on 07/21/26 | ||
| 3-Month | |||||
| %Chg | +63.09% since 05/20/26 | +178.68% since 05/20/26 | -20.13% since 05/20/26 | ||
| Low | 17.90 on 06/08/26 | 4.47 on 05/27/26 | 14.70 on 08/18/26 | ||
| High | 35.41 on 08/19/26 | 15.70 on 08/13/26 | 25.22 on 07/02/26 | ||
| 6-Month | |||||
| %Chg | +92.34% since 02/20/26 | +66.44% since 02/20/26 | -21.52% since 02/20/26 | ||
| Low | 17.41 on 02/23/26 | 1.50 on 04/13/26 | 14.20 on 03/24/26 | ||
| High | 35.41 on 08/19/26 | 15.70 on 08/13/26 | 25.22 on 07/02/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,369,154 | 1,389,148 | 1,345,386 | ||
| Shares Outstanding, K | 39,242 | 93,798 | 85,313 | ||
| Annual Sales, $M | 0 | 0 | 123,670,000 | ||
| Annual Net Income, $M | -63,240,000 | -313,940,000 | -38,630,000 | ||
| Last Qtr Sales, $M | 0 | 0 | 8,970,000 | ||
| Last Qtr Income, $M | -27,640,000 | -69,770,000 | -43,400,000 | ||
| 60-Month Beta | 1.06 | 0.88 | 1.59 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.65 on 08/12/26 | -0.72 on 08/14/26 | -0.43 on 08/06/26 | ||
| Latest Earnings Date | 11/11/26 | 11/05/26 | 11/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||